Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine

Bioorg Med Chem. 2008 May 15;16(10):5653-64. doi: 10.1016/j.bmc.2008.03.066. Epub 2008 Mar 30.

Abstract

A series of 7,8- and 8,9-fused pyrimidinone, aminopyrimidine and pyridone derivatives of 8-carboxamidocyclazocine (8-CAC) have been prepared and evaluated in opioid receptor binding assays. Targets were designed to corroborate a pharmacophore hypothesis regarding the bioactive conformation of the carboxamide of 8-CAC. In addition to the results from this study strongly supporting this pharmacophore hypothesis, a number of novel compounds with high affinity to opioid receptors have been identified.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Azocines / chemical synthesis
  • Azocines / chemistry
  • Azocines / pharmacology*
  • Binding, Competitive / drug effects
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Cyclazocine / analogs & derivatives*
  • Cyclazocine / chemical synthesis
  • Cyclazocine / chemistry
  • Cyclazocine / pharmacology
  • Drug Design
  • Molecular Conformation
  • Narcotic Antagonists*
  • Receptors, Opioid / agonists*
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • 8-carboxamidocyclazocine
  • Azocines
  • Narcotic Antagonists
  • Receptors, Opioid
  • Cyclazocine